NCT04918095Active, not recruiting
CareCOPD - COPD Home Monitoring Study
CareCOPD - Chronic Obstructive Pulmonary Disease (COPD) Home Monitoring for Early Exacerbation Detection
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
This is a pilot study to demonstrate early validation of objective home-monitoring of Chronic obstructive pulmonary disease (COPD) patients by combining accurate and relevant patient data of medication and lung function (lung impedance) through patient-facing devices.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 2 Jun 2021
- Start date
- 9 Nov 2020
- Primary completion date
- 31 May 2028
- Lead sponsor
- Cognita Labs LLC
- Diseases
- COPD
- NCT number
- NCT04918095
What you commit to
- Study type: Observational
- Planned participants: 50
- From 9 Nov 2020 to the primary completion date, 31 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Suffer from any visual, hearing, or cognitive impairment that cannot be corrected enough to operate the CareCOPD devices properly. Mild/moderate vision loss and mild hearing loss may be included with appropriate corrective measures that do not affect the device usage.
- Suffering from serious uncontrolled medical conditions that may interfere with study conduct.
Other
- Subjects who meet any of these criteria are not eligible for enrollment as study participants:
- Physically disabled such that they are incapable of performing forced oscillometry test (for airway impedance measurement)
- Physically disabled such that they are incapable of using metered-dose inhalers.
- Continuous home Oxygen use for greater than 16 hours/day.
- Inability or unwillingness of the participant to give written informed consent.
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
Who the study is looking for
- Patients who meet all of the following criteria are eligible for enrollment as study participants:
- Males and females over the age of 40 years.
- physician-diagnosed COPD classified as GOLD 2-3, C-D for at least 1 year.
- Using rescue medications at home delivered by a metered-dose inhaler or MDI.
- Speak, read, and understand English.
- Able to understand study requirements and comply with study procedures.
- Ability to operate a smartphone or tablet (for questionnaire and symptoms input).
Age in the registry: 40 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ventura County Medical Center Coordinator of this site? Confirm its status | Ventura | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.